BRIEF published on 11/07/2024 at 07:35, 14 days 6 hours ago DEUTZ AG Maintains Profitability Amid Economic Challenges Profitability Revenue Strategy Economic Challenges DEUTZ Cost Program
PRESS RELEASE published on 11/07/2024 at 07:30, 14 days 6 hours ago Amid challenging conditions, DEUTZ remains profitable and provides details of cost program DEUTZ AG remains profitable amid challenging conditions, achieving 4.4% adjusted EBIT margin in the first nine months of 2024. Details of a cost program for permanent savings of €50 million Profitable Adjusted EBIT Margin DEUTZ AG Cost Program Challenging Conditions
BRIEF published on 10/08/2024 at 10:08, 1 month 13 days ago DEUTZ AG Updates Strategy and Implements Cost-Cutting Measures Growth Strategy Portfolio Diversification Cost Reduction DEUTZ AG Revenue Target
PRESS RELEASE published on 10/08/2024 at 10:03, 1 month 13 days ago DEUTZ updates its growth strategy and reduces costs sustainably DEUTZ updates its growth strategy and reduces costs sustainably at Capital Markets Day in Cologne. Revenue target of €4.0 billion by 2030 with new mid-term targets defined Growth Strategy Cost Reduction Capital Markets Day DEUTZ AG Revenue Target
BRIEF published on 10/03/2024 at 13:31, 1 month 18 days ago DEUTZ AG Revises 2024 Forecast Amid Weak Economic Climate Cost-cutting Measures 2024 Forecast Economic Conditions DEUTZ AG Engine Sales
PRESS RELEASE published on 10/03/2024 at 13:26, 1 month 18 days ago EQS-Adhoc: DEUTZ AG adjusts guidance for FY 2024 due to weak demand caused by economic conditions DEUTZ AG adjusts guidance for FY 2024 due to weak demand caused by economic conditions. Revenue and profit margin expectations revised downwards Economic Conditions DEUTZ AG Guidance Adjustment Weak Demand FY 2024
BRIEF published on 09/19/2024 at 17:35, 2 months 1 day ago Change in the CFO Position at DEUTZ AG Corporate Transition DEUTZ AG CFO Change Oliver Neu Timo Krutoff
PRESS RELEASE published on 09/19/2024 at 17:30, 2 months 1 day ago Change in the CFO position at DEUTZ AG DEUTZ AG announces change in CFO position with Timo Krutoff leaving by mutual agreement and Oliver Neu taking over starting October 1, 2024. Neu has extensive financial experience and international background CFO Finance DEUTZ AG Oliver Neu Timo Krutoff
BRIEF published on 08/08/2024 at 07:35, 3 months 13 days ago DEUTZ Maintains Strong Margins Amid Weak Demand in H1 2024 Acquisitions EBIT Margin Strategic Growth DEUTZ AG 2024 Earnings
PRESS RELEASE published on 08/08/2024 at 07:30, 3 months 13 days ago Robust margin for DEUTZ in first half of 2024 despite fall in demand DEUTZ AG reports robust margin in first half of 2024 despite lower demand, achieving 5.7% adjusted EBIT margin. Strategic acquisitions drive future growth Revenue Growth Strategic Acquisitions DEUTZ AG First Half 2024 Robust Margin
Published on 11/21/2024 at 13:30, 27 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 27 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 57 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 57 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 57 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 22 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 42 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
